DigiSensor
A dedicated biosensor chip for continuous measurement. Its time-delay-based signal conversion architecture is designed to digitize biosignals with low power consumption.
Long-duration recording starts with efficient signal acquisition.
R&D
Next Pipeline
Technology Behind AT-Heart
From a small signal to a reviewable ECG record. ATsens develops the sensing hardware, electrode structure and analysis software as one connected system.
Electrode architecture
The electrostatic-protection mesh electrode and impedance-maintaining separation layer are designed to support stable signal acquisition during extended wear.
Signal quality is addressed at the skin-contact interface, before software analysis.
AT-Report
ECG analysis software helps organize recorded data for review. Algorithm evaluation includes noise-stress testing, with the clinical interpretation remaining the responsibility of healthcare professionals.
Hardware and software are developed around the same recorded signal.
From Recording to Clinical Review
AT-Heart connects ECG acquisition, symptom recording and analysis in a shared workflow. The software supports the review process; it does not replace clinical judgement.
- 01 / Record
AT-Patch
A wearable patch collects ECG data during daily activities.
- 02 / Add context
AT-Note
Patients record symptoms to help place ECG data in context.
- 03 / Review
AT-Report
Analysis and reporting tools support review by healthcare professionals.
Product availability, recording duration and supported functions vary by model and market.
Next Pipeline
Shared sensing, signal-quality and analysis expertise informs research into additional biosignals. The images below illustrate application areas, not equivalent regulatory approval or commercial availability.
Conventional measurement
Sleep monitoring 
Blood pressure measurement 
Veterinary measurement 
Glucose measurement 
ECG Holter
Wearable research directions
Sleep-related biosignals 
Blood pressure (in development) 
Veterinary biosignals 
Glucose (planned research) 
Wearable ECG
Development status and intended use differ by application. Research illustrations do not establish clinical performance.
Patents
Total patents
44
-
7
ECG sensing performance
supported by evidence -
17
Up to 14-day continuous
monitoring and ECG
data review -
6
Designed for daily life:
lightweight, wireless,
and daily-use oriented -
10
Physiological signal
monitoring and
data management
AI Algorithm
Proprietary AI algorithms protected by multiple domestic and international patents.
Technology developed to support ECG data review, with regulatory status and clinical evidence varying by market.
Certification
Regulatory Status Across Key Markets.
Availability varies by country and model.
North America
- USA
- Canada
South America
- Brazil
- Peru
- Colombia
- Dominican Republic
- Ecuador
- Argentina
Europe
- Germany
- Greece
- Hungary
- Romania
- Bosnia & Herzegovina
- Serbia & Montenegro
- Spain, Poland
- Italy, The U.K.
- Belarus
Asia
- Hong Kong, Macau
- Sri Lanka, Maldives
- Mongolia, India
- Turkey, Indonesia
- Malaysia
- Thailand
- Singapore
- Vietnam
- Brunei
Middle East
- Cyprus
- KSA
- Kuwait
- Qatar
- UAE
- Oman, Bahrain
- Jordan
- Iraq
- Israel
CIS
- Russia
- Azerbaijan
Oceania
- New Zealand
Africa
- Mauritius
- South Africa
- Senegal, Libya
- Algeria
- Morocco
SCIENTIFIC VALIDATION
Clinical Research & Evidence
The First Everest ECG Explorer
Tough enough for extreme conditions. Published in JAMA Cardiology.
-
Research Partner Bern University Hospital
Switzerland (Inselspital)
-
Participants 30 Healthy Adults
Rigorous selection process
-
Performance Max 14 Days Continuous
Uninterrupted ECG monitoring
ATsens
Publications
Publications